|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.55 SAR | -0.10% |
|
-1.34% | +4.79% |
| 02-13 | Nahdi Medical Dispenses Dose of Growth | |
| 11-18 | Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| SAR 131.28 | +31.87% | 8 | |||||||
| HK$70.44 | +32.55% | 16 | |||||||
| HK$6.185 | +13% | 16 | |||||||
| JP¥3,391 | +25.11% | 10 | |||||||
| ZAR 425.56 | +31.76% | 9 | |||||||
| CN¥32.59 | +31.29% | 12 | |||||||
| CN¥23.84 | +22.24% | 8 | |||||||
| - | - | MX$1,415 | +167.5% | 1 | |||||
| US$35 | +5.58% | 4 | |||||||
| ZAR 38.98 | +7.13% | 8 | |||||||
| €126 | +84.35% | 9 | |||||||
| SAR 66.6 | +32.14% | 7 | |||||||
| CN¥15.8 | +15.31% | 4 | |||||||
| ₹1,069.71 | +25.16% | 7 | |||||||
| - | JP¥5,700 | +21.28% | 2 | ||||||
| R$7.5 | +7.14% | 7 | |||||||
| - | - | SEK 95 | +63.79% | 1 | |||||
| Average | 744.14 | +36.31% | 8 | ||||||
| Weighted average by Cap. | 531.18 | +32.38% | 12 |
- Stock Market
- Equities
- 4164 Stock
- Sector Nahdi Medical Company
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















